These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17096025)

  • 1. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
    Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
    Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells.
    Mangoura D; Sun Y; Li C; Singh D; Gutmann DH; Flores A; Ahmed M; Vallianatos G
    Oncogene; 2006 Feb; 25(5):735-45. PubMed ID: 16314845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
    Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of the NF1 GAP-related domain in NF1-deficient human Schwann cells.
    Thomas SL; Deadwyler GD; Tang J; Stubbs EB; Muir D; Hiatt KK; Clapp DW; De Vries GH
    Biochem Biophys Res Commun; 2006 Sep; 348(3):971-80. PubMed ID: 16908010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
    Kim HA; Rosenbaum T; Marchionni MA; Ratner N; DeClue JE
    Oncogene; 1995 Jul; 11(2):325-35. PubMed ID: 7624147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
    Xu J; Ismat FA; Wang T; Yang J; Epstein JA
    Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor.
    Cichowski K; Santiago S; Jardim M; Johnson BW; Jacks T
    Genes Dev; 2003 Feb; 17(4):449-54. PubMed ID: 12600938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
    Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
    Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
    Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
    Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
    Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos.
    Kuorilehto T; Nissinen M; Koivunen J; Benson MD; Peltonen J
    J Bone Miner Res; 2004 Jun; 19(6):983-9. PubMed ID: 15125795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
    Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K
    Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF1 modulates the effects of Ras oncogenes: evidence of other NF1 function besides its GAP activity.
    Corral T; Jiménez M; Hernández-Muñoz I; Pérez de Castro I; Pellicer A
    J Cell Physiol; 2003 Nov; 197(2):214-24. PubMed ID: 14502561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
    Rosenbaum T; Kim HA; Boissy YL; Ling B; Ratner N
    Ann N Y Acad Sci; 1999 Sep; 883():203-14. PubMed ID: 10586246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
    Dasgupta B; Li W; Perry A; Gutmann DH
    Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
    Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
    Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the Ras-GTPase activating protein neurofibromin by C-tail phosphorylation: implications for protein kinase C/Ras/extracellular signal-regulated kinase 1/2 pathway signaling and neuronal differentiation.
    Leondaritis G; Petrikkos L; Mangoura D
    J Neurochem; 2009 Apr; 109(2):573-83. PubMed ID: 19220708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene.
    Li Y; White R
    Cancer Res; 1996 Jun; 56(12):2872-6. PubMed ID: 8665528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras dependent paracrine secretion of osteopontin by Nf1+/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model.
    Li H; Liu Y; Zhang Q; Jing Y; Chen S; Song Z; Yan J; Li Y; Wu X; Zhang X; Zhang Y; Case J; Yu M; Ingram DA; Yang FC
    Pediatr Res; 2009 Jun; 65(6):613-8. PubMed ID: 19247213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.